Drug products and active pharmaceutical ingredients (APIs) may be contaminated by other drug products or APIs, raw materials, intermediates, cleaning aids, microorganisms, particles and other materials. Contamination causes costly raw materials to be scrapped, triggers regulatory actions and, most importantly, endangers the safety of patients.

In order to avoid contamination of the product, robust cleaning procedures must be performed. Our online meeting facilitates peers’ reflection and discussion on approaches to establishing and revising CV programs to meet regulatory requirements, verifying CV protocols and preventing ineffective or incorrect approaches to cleaning validation programs, risk based cleaning validation, selecting the right equipment/cleaning procedure combinations, testing for API residues and calculating residue limits, considerations on combining cleaning and sanitization, finding and developing practical analytical methods and sampling procedures.

Be a part of our webinar sessions to build practical and compliant cleaning validation program and ensure that the quality of your next product is not affected by contamination.

Click here for more information and to register.